bpc-157 + tb-500 quicksilver scientific Research Peptide Set Liposomal BPC-157 + TB-500 Combo

Animal studies show no toxicity up to high doses, but human reports are anecdotal

This comprehensive approach to quality ensures that the BPC-157 you receive from Peptide Koning meets the exact specifications stated on the product label

Its triple GIP/GLP-1/glucagon agonist mechanism produced the most striking weight-loss numbers ever reported in a Phase 2 trial of an injectable peptide, and its broad TRIUMPH Phase 3 program is poised to expand understanding of how triple receptor modulation affects obesity, diabetes, liver disease, cardiovascular risk, sleep apnea, and musculoskeletal health

Record: Date and time of injection